---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-047595"
form_type: "8-K"
ticker: "BCAB"
cik: "0001826892"
company_name: "BioAtla, Inc."
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T09:49:54.908892+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# BioAtla amends advance notice bylaw for stockholder nominations

## Summary
- Removed requirement to disclose if another person is Acting in Concert with a Proposing Person.
- Clarified that stockholder notice must include names, addresses, and ownership of financial supporters.
- Allowed stockholder to cure deficiencies in Timely Notice by the last day such notice may be delivered.
- Removed requirement to respond within 7 business days to Company inquiries and to submit to interviews.
- Modified definitions of 'Acting in Concert', 'Associated Person', and 'principal competitor'.

## SEC filing metadata
- accession: 0000950170-24-047595
- form_type: 8-K
- ticker: BCAB
- cik: 0001826892
- company_name: BioAtla, Inc.
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826892/000095017024047595/0000950170-24-047595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826892/000095017024047595/bcab-20240422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-047595
- JSON: https://secwatch.observer/filing/0000950170-24-047595.json
- Plain text: https://secwatch.observer/filing/0000950170-24-047595.txt

## Key facts
- Governance Changes
  BioAtla, Inc.: Amended advance notice provisions for stockholder nominations and proposals, removing certain disclosure and interview requirements, clarifying cure periods and disclosure of financial supporters, and modifying definitions (effective 2024-04-22).
  - Change: bylaw amendment
  - Effective: 2024-04-22
  source text: On April 22, 2024, the board of directors (the “Board”) of BioAtla, Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s Amended and Restated Bylaws (the “Bylaws”), which became immediately effective, and include, among other things, the following changes in Article I, Section 2 relating to advance notice requirements applicable to stockholder-submitted nominations and other business proposals (the “Advance Notice Bylaw”): • remove the requirement for a Proposing Person (as defined in the Advance Notice Bylaw) to disclose any knowledge that another person or entity is Acting in Concert (as defined in the Advance Notice Bylaw) in describing the material terms of any agreement, arrangement or understanding entered into for the purpose of acquiring, holding, disposing or voting shares of the Company’s stock; • clarify that a stockholder’s notice required by the Advance Notice Bylaw must disclose the names, addresses and Company stock ownership of record
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826892/000095017024047595/0000950170-24-047595-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.